117 related articles for article (PubMed ID: 24477071)
1. Deep-gray nuclei susceptibility-weighted imaging filtered phase shift in patients with Wilson's disease.
Bai X; Wang G; Wu L; Liu Y; Cui L; Shi H; Guo L
Pediatr Res; 2014 Mar; 75(3):436-42. PubMed ID: 24477071
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility-Weighted Imaging Manifestations in the Brain of Wilson's Disease Patients.
Yang J; Li X; Yang R; Yu X; Yu C; Qian Y; Yu Y
PLoS One; 2015; 10(4):e0125100. PubMed ID: 25915414
[TBL] [Abstract][Full Text] [Related]
3. The asymmetry of neural symptoms in Wilson's disease patients detecting by diffusion tensor imaging, resting-state functional MRI, and susceptibility-weighted imaging.
Zhou XX; Li XH; Chen DB; Wu C; Feng L; Chu JP; Yang ZY; Li XB; Qin H; Li GD; Huang HW; Liang YY; Liang XL
Brain Behav; 2018 May; 8(5):e00930. PubMed ID: 29761003
[TBL] [Abstract][Full Text] [Related]
4. Characterizing brain mineral deposition in patients with Wilson disease using susceptibility-weighted imaging.
Zhou XX; Qin HL; Li XH; Huang HW; Liang YY; Liang XL; Pu XY
Neurol India; 2014; 62(4):362-6. PubMed ID: 25237939
[TBL] [Abstract][Full Text] [Related]
5. Magnetic Susceptibility Changes in the Basal Ganglia and Brain Stem of Patients with Wilson's Disease: Evaluation with Quantitative Susceptibility Mapping.
Doganay S; Gumus K; Koc G; Bayram AK; Dogan MS; Arslan D; Gumus H; Gorkem SB; Ciraci S; Serin HI; Coskun A
Magn Reson Med Sci; 2018 Jan; 17(1):73-79. PubMed ID: 28515413
[TBL] [Abstract][Full Text] [Related]
6. SWI phase asymmetries in deep gray matter of healthy adults: is there an association with handedness?
Liu Y; Wang G; Zhao L; Geng M; Wang L; Bai X; Hu J; Man X
Brain Imaging Behav; 2013 Jun; 7(2):220-6. PubMed ID: 23329356
[TBL] [Abstract][Full Text] [Related]
7. Cranial MR imaging in Wilson's disease.
King AD; Walshe JM; Kendall BE; Chinn RJ; Paley MN; Wilkinson ID; Halligan S; Hall-Craggs MA
AJR Am J Roentgenol; 1996 Dec; 167(6):1579-84. PubMed ID: 8956601
[TBL] [Abstract][Full Text] [Related]
8. Whole brain volume and cortical thickness abnormalities in Wilson's disease: a clinical correlation study.
Song Y; Zou L; Zhao J; Zhou X; Huang Y; Qiu H; Han H; Yang Z; Li X; Tang X; Chu J
Brain Imaging Behav; 2021 Aug; 15(4):1778-1787. PubMed ID: 33052506
[TBL] [Abstract][Full Text] [Related]
9. Brain susceptibility changes in neurologically asymptomatic pediatric patients with Wilson's disease: evaluation with quantitative susceptibility mapping.
Saracoglu S; Gumus K; Doganay S; Koc G; Kacar Bayram A; Arslan D; Gumus H
Acta Radiol; 2018 Nov; 59(11):1380-1385. PubMed ID: 29482344
[TBL] [Abstract][Full Text] [Related]
10. [Clinical characteristics of patients with delayed hepatolenticular degeneration].
Zhou XX; Qin HL; He RX; Chen DB; Wu C; Feng L; Li XH; Liang XL
Zhonghua Nei Ke Za Zhi; 2019 Jul; 58(7):501-507. PubMed ID: 31269566
[No Abstract] [Full Text] [Related]
11. Seven-tesla magnetic resonance imaging in Wilson disease using quantitative susceptibility mapping for measurement of copper accumulation.
Fritzsch D; Reiss-Zimmermann M; Trampel R; Turner R; Hoffmann KT; Schäfer A
Invest Radiol; 2014 May; 49(5):299-306. PubMed ID: 24220252
[TBL] [Abstract][Full Text] [Related]
12. Quantitative Measurement of Metal Accumulation in Brain of Patients With Wilson's Disease.
Li G; Wu R; Tong R; Bo B; Zhao Y; Gillen KM; Spincemaille P; Ku Y; Du Y; Wang Y; Wang X; Li J
Mov Disord; 2020 Oct; 35(10):1787-1795. PubMed ID: 32681698
[TBL] [Abstract][Full Text] [Related]
13. Paramagnetic Metal Accumulation in the Deep Gray Matter Nuclei Is Associated With Neurodegeneration in Wilson's Disease.
Yuan XZ; Li GY; Chen JL; Li JQ; Wang XP
Front Neurosci; 2020; 14():573633. PubMed ID: 33041766
[TBL] [Abstract][Full Text] [Related]
14. Widespread cerebral cortical mineralization in Wilson's disease detected by susceptibility-weighted imaging.
Lee JH; Yang TI; Cho M; Yoon KT; Baik SK; Han YH
J Neurol Sci; 2012 Feb; 313(1-2):54-6. PubMed ID: 22014607
[TBL] [Abstract][Full Text] [Related]
15. [Difference in imaging and metal metabolism between hepatic and cerebral type Wilson disease].
Zhou XX; Li XH; Pu XY; Qin HL; Li XB; Chu JP; Yang ZY; Huang HW; Liang XL
Zhonghua Yi Xue Za Zhi; 2017 Jan; 97(3):176-181. PubMed ID: 28162166
[No Abstract] [Full Text] [Related]
16. Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis: a case-control study.
Zivadinov R; Heininen-Brown M; Schirda CV; Poloni GU; Bergsland N; Magnano CR; Durfee J; Kennedy C; Carl E; Hagemeier J; Benedict RH; Weinstock-Guttman B; Dwyer MG
Neuroimage; 2012 Jan; 59(1):331-9. PubMed ID: 21820063
[TBL] [Abstract][Full Text] [Related]
17. Changes in brain susceptibility in Wilson's disease patients: a quantitative susceptibility mapping study.
Deng W; Zhang J; Yang J; Wang Z; Pan Z; Yue X; Zhao R; Qian Y; Yu Y; Li X
Clin Radiol; 2024 Feb; 79(2):e282-e286. PubMed ID: 38087682
[TBL] [Abstract][Full Text] [Related]
18. The diagnostic value of multimodal evoked potentials in the determination of subclinical neurological involvement of Wilson's disease.
Ecevit C; Ozgenç F; Gökçay F; Celebisoy N; Baran M; Yağci RV
Eur J Gastroenterol Hepatol; 2012 Jun; 24(6):627-32. PubMed ID: 22433793
[TBL] [Abstract][Full Text] [Related]
19. Clinical features, MRI brain, and MRS abnormalities of drug-naïve neurologic Wilson's disease.
Pulai S; Biswas A; Roy A; Guin DS; Pandit A; Gangopadhyay G; Ghorai PK; Sarkhel S; Senapati AK
Neurol India; 2014; 62(2):153-8. PubMed ID: 24823724
[TBL] [Abstract][Full Text] [Related]
20. Multiparametric Quantitative Brain MRI in Neurological and Hepatic Forms of Wilson's Disease.
Dezortova M; Lescinskij A; Dusek P; Herynek V; Acosta-Cabronero J; Bruha R; Jiru F; Robinson SD; Hajek M
J Magn Reson Imaging; 2020 Jun; 51(6):1829-1835. PubMed ID: 31710776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
